Peroxisome Proliferator-Activated Receptors and the Control of Fatty Acid Oxidation in Cardiac Hypertrophy

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 3, 2006-03 ,pp. : 357-363

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome proliferator activated receptors and obesity

By Kersten S.  

European Journal of Pharmacology, Vol. 440, Iss. 2, 2002-04 ,pp. : 223-234

Elsevier

Access to resources Recommend Favorite

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor- , reduces acute inflammation

By Cuzzocrea S.   Pisano B.   Dugo L.   Ianaro A.   Maffia P.   Patel N.S.A.   Di Paola R.   Ialenti A.   Genovese T.   Chatterjee P.K.   Di Rosa M.   Caputi A.P.   Thiemermann C.  

European Journal of Pharmacology, Vol. 483, Iss. 1, 2004-01 ,pp. : 79-93

Elsevier

Access to resources Recommend Favorite

Targeting the peroxisome proliferator-activated receptors (PPARs) in spinal cord injury

By Esposito Emanuela   Cuzzocrea Salvatore  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 8, 2011-08 ,pp. : 943-959

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptors ligands and ischemia-reperfusion injury

By Paola Rosanna   Cuzzocrea Salvatore  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 3, 2007-05 ,pp. : 157-175

Springer Publishing Company

Access to resources Recommend Favorite